NovaBay Pharmaceuticals, Inc. (NBY) Total Return Calculator with Dividends Reinvested

NovaBay Pharmaceuticals, Inc.

Popular:

The total return for NovaBay Pharmaceuticals, Inc. (NBY) stock is +79.34% over the past 12 months. So far it's down 94.99% this year. The 5-year total return is -99.88%, meaning $10,000 invested in NBY stock 5 years ago would be worth $12 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in NBY 1 year ago, it would be worth $8,381 today — you'd have lost $1,619 with dividends reinvested.

With Dividends Reinvested$8,381-16.19%

Price Only (No DRIP)$5,158-48.42%

Dividend Boost+$3,2231 payments · +32.23% extra

Period2025-06-23 → 2026-05-22

Price

Total Return (DRIP)

Dividends

S&P 500

If You Invested $10,000 in NBY

1Y$17,934+$7,934 (+79.3%)79.3% CAGR

3Y$423-$9,577 (-95.8%)-65.2% CAGR

5Y$12-$9,988 (-99.9%)-73.7% CAGR

10Y$3-$9,997 (-100.0%)-55.2% CAGR

15Y$0-$10,000 (-100.0%)-49.6% CAGR

20Y$0-$10,000 (-100.0%)-45.7% CAGR

30Y$0-$10,000 (-100.0%)-33.4% CAGR

Dividend Reinvestment History (1)▲ Hide

Ex-Date	Dividend	Reinvest Price	Shares Added
2025-09-30	$4.00	$6.40	+0.625000

Loading NBY total return...

As of 2026-06-19

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-94.99%	—	-94.99%	—	$501
1Y	+79.34%	79.34%	-51.81%	+131.15 pp	$17,934
3Y	-95.77%	-65.17%	-98.86%	+3.09 pp	$423
5Y	-99.88%	-73.75%	-99.97%	+0.09 pp	$12
10Y	-99.97%	-55.18%	-99.99%	+0.02 pp	$3
15Y	-100.00%	-49.64%	-100.00%	—	$0
20Y	-100.00%	-45.68%	-100.00%	—	$0
30Y	-100.00%	-33.43%	-100.00%	—	$0

Risk & Highlights

Best Year+826.52%2025

Worst Year-91.32%2023

Max Drawdown-98.79%2026-01-09 → 2026-03-20

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-95.09%	-95.09%	—	+0.41%	-95.5pp
2025	+826.52%	+800.96%	+25.6pp	+16.64%	+809.9pp
2024	-91.16%	-91.16%	—	+24.00%	-115.2pp
2023	-91.32%	-91.32%	—	+24.81%	-116.1pp
2022	-86.03%	-86.03%	—	-19.95%	-66.1pp

NBY outperformed the S&P 500 by 54.35pp over the past year (+79.34% vs +24.99%).

Loading summary...

NBY Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
NBYNovaBay Pharmaceuticals, Inc.	$9M	+0.0%	-95.0%	+79.3%	+131.1pp	-95.8%	-99.9%	-100.0%
AYTUAytu BioPharma, Inc.	$18M	+10.0%	-16.6%	+17.3%	—	+30.5%	-97.6%	-100.0%
PRPHProPhase Labs, Inc.	$369,487	-28.0%	-79.2%	-79.5%	—	-97.9%	-76.1%	+23.2%
OGENOragenics, Inc.	$3M	-3.8%	-34.6%	-85.2%	—	-99.4%	-100.0%	-100.0%
CTXRCitius Pharmaceuticals, Inc.	$6M	+3.7%	-35.6%	-40.1%	—	-98.3%	-99.4%	-99.8%
PCYOPure Cycle Corporation	$270M	+6.0%	+2.4%	+9.6%	—	-0.4%	-16.4%	+137.0%
PAHCPhibro Animal Health Corporation	$1.3B	-6.8%	-14.0%	+34.9%	+2.0pp	+138.3%	+16.6%	+87.9%
DERMJourney Medical Corporation	$177M	-0.5%	-16.5%	-2.0%	—	+199.0%	-34.5%	-34.5%
CLXThe Clorox Company	$11.0B	+3.2%	-2.5%	-16.7%	+4.1pp	-29.0%	-30.7%	+5.0%
PGThe Procter & Gamble Company	$345.1B	+5.6%	+7.6%	-2.1%	+2.7pp	+9.7%	+28.6%	+122.1%
HSICHenry Schein, Inc.	$9.0B	+9.9%	+4.0%	+12.4%	—	+2.6%	+6.5%	+16.6%

Compare:NBY vs AYTU NBY vs PRPH NBY vs OGEN NBY vs AYTU vs PRPH

About NBY Dividend Returns

NovaBay Pharmaceuticals, Inc. (NBY) is a dividend-paying stock. When dividends are reinvested through a DRIP (Dividend Reinvestment Plan), they purchase additional shares, which then generate their own dividends—creating a compounding effect that can significantly boost long-term returns.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of NBY over the past year?

NovaBay Pharmaceuticals, Inc. (NBY) delivered a total return of 79.34% over the past year when dividends are reinvested. The price-only return was -51.81%, meaning dividends contributed an additional 131.15 percentage points to total returns.

Q2How much would $10,000 invested in NBY be worth today?

A $10,000 investment in NovaBay Pharmaceuticals, Inc. one year ago would be worth $17,934 today with dividends reinvested (DRIP). Without reinvesting dividends, the same investment would be worth $4,819. Dividend reinvestment added $13,115 to the portfolio value.

Q3Does NBY pay dividends?

Yes, NovaBay Pharmaceuticals, Inc. (NBY) pays dividends. In the last year, NBY paid approximately $0.00 per share in dividends. Reinvesting these dividends through a DRIP can significantly boost long-term returns — over 20+ years, dividend compounding can account for 30–50% of total returns for dividend-paying stocks.

Q4Did NBY beat the S&P 500?

Yes, NovaBay Pharmaceuticals, Inc. (NBY) outperformed the S&P 500 by 54.35 percentage points over the past year. NBY delivered a total return of 79.34%, compared to the S&P 500's 24.99%. This 54.35pp alpha means investors in NBY earned more than a passive S&P 500 index fund.

Q5What is NBY's worst drawdown?

NovaBay Pharmaceuticals, Inc. (NBY) experienced a maximum drawdown of -98.79% over the past year, declining from its peak on 2026-01-09 to its trough on 2026-03-20. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is NBY's long-term total return over 10, 20, or 30 years?

Here are NovaBay Pharmaceuticals, Inc. (NBY)'s long-term returns with dividends reinvested. Over 10 years, the total return is -100.0% (-55.2% CAGR) — $10,000 would have grown to $3. Over 20 years: -100.0% total return (-45.7% CAGR) — $10,000 → $0. Over 30 years: -100.0% total return (-33.4% CAGR) — $10,000 → $0. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was NBY's best and worst year?

NovaBay Pharmaceuticals, Inc.'s best calendar year was 2025 with a total return of 826.5%. Its worst year was 2023 with a total return of -91.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 917.8 percentage points.

How much would $100/month in NBY be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →